FundedIQ
Biotechnology

Argonaute RNA: Funding, Investors & Team (Nov 2026)

Argonaute RNA company research projects build on existing intellectual property.

argonauterna.com LinkedIn Bristol, United Kingdom 11-50 employees Founded 2015
Total raised
$1.8M
Rounds
1
Latest
Undisclosed round
Sep 2026

Argonaute RNA has raised $1.8M across 1 funding round on record, the most recent an undisclosed round of $1.8M announced in Sep 2026.

That round is below the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Argonaute RNA Company Profile and Key Stats

Total funding raised
$1.8M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$1.8M in Sep 2026
Employees
11-50
reported band
Founded
2015
Headquarters
Bristol, United Kingdom
Investors on record
4
4 named below

Latest funding round on record: Sep 2026.

Argonaute RNA Funding Rounds

Date
Round
Amount
Undisclosed round
$1.8M

Argonaute RNA Investors

Development Bank of Wales Empirical Ventures The Fink Family Office Bristol Private Equity Club

Argonaute RNA Founders and Leadership Team

Name
Role
Contact
Michael Khan
Chief Executive Officer
Locked

Contact details for the Argonaute RNA team: 1 of 1 has an email address on file, 1 has a LinkedIn profile.

Start 14-day free trial →

Argonaute RNA Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
5,418
$4.4M

Argonaute RNA's latest round of $1.8M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Argonaute RNA in Biotechnology and Bristol

Companies Similar to Argonaute RNA

Bit.bio specializes in the fields of coding and biology that determine the identity of every human cell.…

Series D $25.0M

Bioliberty is a young healthcare technology company that focuses on creating innovative rehabilitation…

Series A $3.3M

Microbiotica develops treatments involving live bacteria found in the human microbiome, aiming to identify…

Series C $40.4M

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop…

Series C $310M

HydRegen, based in Oxford, UK, is a biotech firm that offers eco-friendly alternatives for the production of…

Series A $8.0M

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

Argonaute RNA Funding FAQs

What does Argonaute RNA do?

Argonaute RNA company research projects build on existing intellectual property.

How much funding has Argonaute RNA raised?

Argonaute RNA has raised $1.8M across 1 round on record. The most recent is an undisclosed round of $1.8M announced in Sep 2026.

When did Argonaute RNA last raise funding?

Argonaute RNA's most recent funding round on record is an undisclosed round of $1.8M, announced in Sep 2026.

Who has invested in Argonaute RNA?

Investors on record for Argonaute RNA include Development Bank of Wales, Empirical Ventures, The Fink Family Office, Bristol Private Equity Club.

Who is the CEO of Argonaute RNA?

Michael Khan is listed as Chief Executive Officer at Argonaute RNA.

Where is Argonaute RNA headquartered?

Argonaute RNA is based in Bristol, United Kingdom.

How many employees does Argonaute RNA have?

Argonaute RNA is in the 11-50 employee band.

When was Argonaute RNA founded?

Argonaute RNA was founded in 2015.

How does Argonaute RNA's funding compare to other Biotechnology startups?

Argonaute RNA's latest round of $1.8M is below the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's Argonaute RNA Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Argonaute RNA is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.